QNRX Quoin Pharmaceuticals, Ltd.

Nasdaq quoinpharma.com


$ 12.66 $ -0.28 (-2.17 %)    

Wednesday, 29-Oct-2025 14:13:32 EDT
QQQ $ 634.49 $ -1.08 (-0.17 %)
DIA $ 478.02 $ -0.72 (-0.15 %)
SPY $ 687.54 $ -1.21 (-0.18 %)
TLT $ 91.42 $ -0.46 (-0.5 %)
GLD $ 366.85 $ -2.80 (-0.76 %)
$ 12.98
$ 12.91
$ 12.55 x 100
$ 13.00 x 2
$ 12.50 - $ 12.77
$ 5.01 - $ 48.30
34,460
na
2.75M
$ 0.95
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-13-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-14-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-15-2023 12-31-2022 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 quoin-pharmaceuticals-announces-recruitment-of-three-additional-pediatric-patients-for-its-investigator-led-netherton-syndrome-study-and-reports-9-month-results-from-the-first-patient-treated-with-qrx003-showing-completely-healed-skin-after-9-months-of-whole-body-treatment

Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) (the "Company" or "Quoin"), a late clinical stage, specialty pharmaceu...

 quoin-pharmaceuticals-qnrx-stock-is-skyrocketing-friday-whats-going-on

Quoin Pharmaceuticals shares are trading higher Friday morning after the company announced a private placement financing of up ...

 quoin-pharma-announces-1045m-private-placement-including-165m-upfront-and-88m-in-warrant-linked-upside-priced-above-prior-close

Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceut...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION